Stamatios Kioufis
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.
Journal: Cardiology
Published: May 04, 2016
Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel.
Journal: International journal of cardiology
Published: January 19, 2016
Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment.
Journal: Current pharmaceutical design
Published: April 27, 2015
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Journal: Atherosclerosis
Published: April 12, 2015
Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel.
Journal: International journal of cardiology
Published: October 15, 2014
High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel.
Journal: International journal of cardiology
Published: June 27, 2014
Vitamin D3, D2 and arterial wall properties in coronary artery disease.
Journal: Current pharmaceutical design
Published: May 04, 2014
The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease.
Journal: International journal of cardiology
Published: December 31, 2013
Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease.
Journal: International journal of cardiology
Published: May 15, 2013
The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel.
Journal: International journal of cardiology
Published: October 17, 2012
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
Journal: International journal of cardiology
Published: March 07, 2012
Biomarkers determining cardiovascular risk in patients with kidney disease.
Journal: Current medicinal chemistry
Published: October 10, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026